ArticleCellular and molecular bioengineering2021

Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis.

T C L Kohs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.